The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $78.91

Today's change+1.81 +2.35%
Updated July 25 4:01 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $78.91

Today's change+1.81 +2.35%
Updated July 25 4:01 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp crosses above 50-day moving average

CVS Health Corp closed up sharply Tuesday, rallying (U.S.)$1.81 or 2.35% to (U.S.)$78.91 and crossing above its 50-day moving average. Over the last five days, shares have gained 1.17%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 30.32% during the last year.

Key company metrics

  • Open(U.S.) $77.48
  • Previous close(U.S.) $77.10
  • High(U.S.) $78.97
  • Low(U.S.) $77.25
  • Bid / Ask(U.S.) $76.50 / (U.S.) $78.91
  • YTD % change+0.00000%
  • Volume4,553,528
  • Average volume (10-day)4,723,903
  • Average volume (1-month)6,080,672
  • Average volume (3-month)6,291,388
  • 52-week range(U.S.) $69.30 to (U.S.) $98.66
  • Beta0.91
  • Trailing P/E16.37×
  • P/E 1 year forward13.14×
  • Forward PEG1.67×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.53%
  • Trailing EPS(U.S.) $4.82
Updated July 25 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.49%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue44,51445,97144,61543,725
Total other revenue--------
Total revenue44,51445,97144,61543,725
Gross profit6,5807,6067,4927,015
Total cost of revenue37,93438,36537,12336,710
Total operating expense42,72142,97641,89941,917
Selling / general / administrative4,7874,6114,6754,665
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--0101542
Other operating expenses, total--------
Operating income1,7932,9952,7161,808
Interest income (expense), net non-operating-258-248-258-284
Gain (loss) on sale of assets--------
Other--------
Income before tax1,5342,7532,4631,528
Income after tax9621,7071,542924
Income tax, total5721,046921604
Net income9521,7071,540924
Total adjustments to net income5-9-6-4
Net income before extra. items9611,7071,541924
Minority interest-10-10
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9661,6981,535920
Inc. avail. to common incl. extra. items9571,6981,534920
Diluted net income9571,6981,534924
Dilution adjustment------4
Diluted weighted average shares1,0351,0701,0731,075
Diluted EPS excluding extraordinary itemsvalue per share0.931.591.430.86
Dividends per sharevalue per share0.500.430.430.43
Diluted normalized EPSvalue per share0.931.591.491.16